Effect of TMS on PTSD Biomarkers
NCT: NCT04563078 · COMPLETED
Brief Summary
The study will (1) assess feasibility of a TMS treatment in an underserved population; (2) determine if this TMS treatment protocol improves PTSD symptoms and biological markers of PTSD such as brain functioning and startle responses; (3) define new brain targets for future TMS studies; (4) provide the first data for individual differences, which will help personalize treatment for PTSD patients; (5) improve knowledge of the neurobiology of PTSD and treatment response.
Frequently Asked Questions
What is Effect of TMS on PTSD Biomarkers?
Effect of TMS on PTSD Biomarkers is a clinical trial registered under NCT04563078. Current status: COMPLETED.
What is the status of NCT04563078?
The current status of NCT04563078 (Effect of TMS on PTSD Biomarkers) is: COMPLETED.
When did Effect of TMS on PTSD Biomarkers start?
Effect of TMS on PTSD Biomarkers started on 2021-02-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.